Disease/Infection News

RSS

Acid ceramidase is a SARS-CoV-2 host factor, study says

Fluoxetine, a common antidepressant, inhibits the SARS-CoV-2 coronavirus in cell cultures and in preparations from human lung tissue. This was demonstrated by researchers at Julius-Maximilians-Universität (JMU) Würzburg in the summer of 2020. However, the mechanism of this inhibition was utterly unclear, so the teams continued their research.

17 Aug 2022

Study provides insights into understanding the biology of circulating Hepatitis E variants

Over three million people are infected with the hepatitis E virus every year. So far, no effective treatment is available. An international team has investigated which factors are important for the virus in the course of its replication cycle and how it manages to maintain the infection.

17 Aug 2022

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

A recent article demonstrated that BCG vaccinations might offer a platform for protection against emerging SARS-CoV-2 variants and other pathogenic infections in type 1 diabetics.

17 Aug 2022

The neutralizing antibody escape of BA.2.75 in mRNA-vaccinated and BA.1-infected individuals

Investigators analyzed the neutralization escape of the SARS-CoV-2 Omicron BA.2.75 variant.

17 Aug 2022

The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

Researchers demonstrated the relevance of the P681H spike mutation in the SARS-CoV-2 Alpha variant.

17 Aug 2022

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

A pioneering genomic surveillance study has provided the clearest picture yet of the arms race between Streptococcus pneumoniae, the bacterium responsible for a range of illnesses such as pneumonia and meningitis, and the vaccines designed to protect against the most dominant types. A strain called GPSC10 was found to be a particular threat, due to its increased virulence, ability to transform its structure to evade vaccines and its resistance to several common antibiotics.

17 Aug 2022

Human-to-dog transmission of monkeypox virus reported

Researchers describe the first confirmed case of monkeypox virus infection in a dog as a result of human transmission.

17 Aug 2022

A dermatological approach to diagnosing monkeypox

Scientists present their dermatological approach to a suspected monkeypox case.

16 Aug 2022

Can evolutionary principles lead to new treatments or vaccines for monkeypox?

Researchers question whether evolution can assist in the development of new treatments and vaccines to combat the current monkeypox outbreak.

16 Aug 2022

Understanding COVID aerosol dispersion from wind musical instruments

During the COVID-19 pandemic, many live musical events and festivals were postponed and even canceled to protect musicians and audience members.

16 Aug 2022

How useful is PCR for diagnosing monkeypox?

Researchers explore the reliability of PCR for monkeypox diagnosis.

16 Aug 2022

SARS-CoV-2 evolution within hosts and vaccination effects

A new study explores the mutational profiles within individuals infected with SARS-CoV-2.

16 Aug 2022

Study estimates level of protection induced by booster doses of mRNA COVID-19 vaccine

A team of scientists has recently conducted a study to understand the association between magnitudes of COVID-19 vaccine-induced antibodies and the level of protection against SARS-CoV-2 infection.

16 Aug 2022

Antiviral drugs in combination with antibody therapies could help protect people from the flu pandemic

Researchers at McMaster University have found a class of well-known antiviral drugs could be part of a one-two punch to treat seasonal influenza and prevent a flu pandemic when used in combination with antibody therapies.

16 Aug 2022

CSU part of $12.5 million-supported institute to advance virus research and education

Colorado State University researchers are part of a $12.5 million National Science Foundation-supported institute that will advance research and education around viral emergence – the process of viruses jumping from animals to humans.

16 Aug 2022

LSHTM expert comment: UK's MHRA approves bivalent COVID-19 vaccine

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved a booster vaccine made by Moderna which targets two COVID-19 variants, known as a bivalent vaccine. Following clinical trial data that showed it triggers a strong immune response against both strains, the vaccine was found to meet the UK regulator's standards for safety, quality and effectiveness. Vaccine expert, Professor Beate Kampmann reacts to this announcement.

16 Aug 2022

Disease/Infection News

Acid ceramidase is a SARS-CoV-2 host factor, study says

Study provides insights into understanding the biology of circulating Hepatitis E variants

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

The neutralizing antibody escape of BA.2.75 in mRNA-vaccinated and BA.1-infected individuals

The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

Human-to-dog transmission of monkeypox virus reported

A dermatological approach to diagnosing monkeypox

Can evolutionary principles lead to new treatments or vaccines for monkeypox?

Understanding COVID aerosol dispersion from wind musical instruments

How useful is PCR for diagnosing monkeypox?

SARS-CoV-2 evolution within hosts and vaccination effects

Study estimates level of protection induced by booster doses of mRNA COVID-19 vaccine

Antiviral drugs in combination with antibody therapies could help protect people from the flu pandemic

CSU part of $12.5 million-supported institute to advance virus research and education

LSHTM expert comment: UK's MHRA approves bivalent COVID-19 vaccine

Do our tonsils absorb nanoplastics?

What is the impact of COVID-19 on maternal, fetal, and neonatal characteristics?

Report documents the detection of monkeypox virus in anal samples taken from asymptomatic MSM

What are the risk factors related to COVID-19-related hospitalization and mortality?

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News